ENTITY HRS-3005

HRS-3005

PulseAugur coverage of HRS-3005 — every cluster mentioning HRS-3005 across labs, papers, and developer communities, ranked by signal.

Total · 30d

1

1 over 90d

Releases · 30d

0

0 over 90d

Papers · 30d

1

1 over 90d

TIER MIX · 90D

RECENT · PAGE 1/1 · 1 TOTAL

TOOL · CL_22738 · May 8 · 08:26

Henrui Medicine's HRS-3005 tablet receives approval for clinical trials in B-cell malignancies

Henrui Pharmaceutical has received approval from China's National Medical Products Administration to conduct clinical trials for its HRS-3005 tablets. This innovative anti-tumor drug, developed in-house, is intended for…